Eczema overlooked? Harris Poll finds low-key social media profile even as new meds flood the market
Eczema, or atopic dermatitis, has kept a fairly low profile among social media influencers. However, with a handful of newly approved treatment options over the past year and new advertising and marketing campaign launches, that relative quiet may be about to change.
The Harris Poll tapped into its social media expert network monitoring eczema for Endpoints News to see where the industry stands currently. Its research shows a relatively low-profile condition on one hand, but plenty of opportunity on the other.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 159,000+ biopharma pros reading Endpoints daily — and it's free.